Join to View Full Profile
6569 N Charles StSuite 201Baltimore, MD 21204
Phone+1 443-849-3051
Fax+1 443-849-3057
Dr. Levine is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Beth Israel Deaconess Medical CenterResidency, Internal Medicine, 1975 - 1976
National Institutes of Health Clinical CenterFellowship, Hematology and Medical Oncology, 1972 - 1975- Beth Israel Deaconess Medical CenterResidency, Surgery, 1970 - 1972
University of Colorado School of Medicine Anschutz Medical CampusClass of 1970
Certifications & Licensure
MD State Medical License 1975 - 2026
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- Fellow (FACP) American College of Physicians, 2001
Clinical Trials
- Study to Compare the Overall Survival of Patients Receiving INGN 201 (Study Drug) With Patients Receiving Methotrexate
- Effectiveness and Safety of INGN 201 in Combination With Chemotherapy Versus Chemotherapy Alone
- Chemotherapy With or Without Bevacizumab in Treating Patients With Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma Start of enrollment: 2008 Aug 08
- Join now to see all
Publications & Presentations
PubMed
- A new prognostic model in chemotherapy-treated patients with recurrent or metastatic head and neck cancer: An analysis of ECOG-ACRIN E1305.Athanassios Argiris, Yael Flamand, Panayiotis Savvides, Jennifer M Johnson, Ioannis Vathiotis
European Journal of Cancer. 2024-03-01 - 64 citationsPhase III Randomized Trial of Chemotherapy With or Without Bevacizumab in Patients With Recurrent or Metastatic Head and Neck Cancer.Athanassios Argiris, Shuli Li, Panayiotis Savvides, James Ohr, Jill Gilbert
Journal of Clinical Oncology. 2019-10-16 - 2 citationsCorrection: Tadalafil Augments Tumor-specific Immunity in Patients with Head and Neck Squamous Cell Carcinoma.Joseph A. Califano, Zubair Khan, Kimberly A. Noonan, Lakshmi Rudraraju, Zhe Zhang
Clinical Cancer Research. 2018-12-01
Professional Memberships
- Member
- Fellow
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
